We have funded ground-breaking studies, such as the Heart Protection Study, where large numbers of patients have taken part to help further our knowledge of heart disease. It's important that the public has confidence in the work we fund, which is why transparency in the work we fund and publication of the results is essential.
Every researcher that we fund must, as a condition of their award, deposit an electronic copy of each primary research paper funded by us into the freely accessible online resource Europe PubMed Central within 6 months of publication.
This also applies to work we part-fund and helps to ensure that the findings from the research we fund is made freely available to all.
The clinical trials we fund that test medicines are registered within the EU's EudraCT clinical trials database. Trials that we fund ideally publish their results within a year of completion, and it is important that the results are published in a format that is of use to researchers.
We are pleased to support the AllTrials initiative aimed at increasing transparency in clinical trials.
For further information, please contact us at email@example.com.